- Home
- SFBS vs PCVX Comparison
SFBS vs PCVX Comparison
Compare SFBS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBS
- PCVX
- Stock Information
- Founded
- SFBS 2005
- PCVX 2013
- Country
- SFBS United States
- PCVX United States
- Employees
- SFBS N/A
- PCVX N/A
- Industry
- SFBS Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SFBS Finance
- PCVX Health Care
- Exchange
- SFBS Nasdaq
- PCVX Nasdaq
- Market Cap
- SFBS 4.1B
- PCVX 4.2B
- IPO Year
- SFBS 2014
- PCVX 2020
- Fundamental
- Price
- SFBS $72.93
- PCVX $32.87
- Analyst Decision
- SFBS Hold
- PCVX Strong Buy
- Analyst Count
- SFBS 1
- PCVX 10
- Target Price
- SFBS $84.00
- PCVX $136.50
- AVG Volume (30 Days)
- SFBS 173.7K
- PCVX 1.6M
- Earning Date
- SFBS 07-14-2025
- PCVX 08-05-2025
- Dividend Yield
- SFBS 1.84%
- PCVX N/A
- EPS Growth
- SFBS 20.55
- PCVX N/A
- EPS
- SFBS 4.40
- PCVX N/A
- Revenue
- SFBS $477,064,000.00
- PCVX N/A
- Revenue This Year
- SFBS $25.60
- PCVX N/A
- Revenue Next Year
- SFBS $13.11
- PCVX N/A
- P/E Ratio
- SFBS $16.44
- PCVX N/A
- Revenue Growth
- SFBS 17.21
- PCVX N/A
- 52 Week Low
- SFBS $58.51
- PCVX $27.66
- 52 Week High
- SFBS $101.37
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SFBS 44.99
- PCVX 43.55
- Support Level
- SFBS $71.27
- PCVX $33.24
- Resistance Level
- SFBS $73.74
- PCVX $34.94
- Average True Range (ATR)
- SFBS 1.39
- PCVX 1.55
- MACD
- SFBS -0.24
- PCVX -0.07
- Stochastic Oscillator
- SFBS 29.96
- PCVX 6.28
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.